MYMartha Yocupicio-Monroy

Martha Yocupicio-Monroy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martha Yocupicio-Monroy has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparative genomic analysis of Pseudomonas aeruginosa strains susceptible and resistant to carbapenems and aztreonam isolated from patients with healthcare-associated infections in a Mexican hospital

    by María José Martínez-Gallardo, Claudia Villicaña, Martha Yocupicio-Monroy, Sofía Lizeth Alcaraz-Estrada, Juana Salazar-Salinas, Omar Fernando Mendoza-Vázquez, Gabriel Damazo-Hernández, Josefina León-Félix

    Pseudomonas aeruginosa (PA) is an important opportunistic pathogen that causes different infections on immunocompromised patients. Within PA accessory genome, differences in virulence, antibiotic resistance and biofilm formation have been described between strains, leading to the emergence of multidrug-resistant strains. The genome sequences of 17 strains isolated from patients with healthcare-associated infections in a Mexican hospital were genomically and phylogenetically analyzed and antibiotic resistance genes, virulence genes, and biofilm formation genes were detected. Fifteen of the 17 strains were resistant to at least two of the carbapenems meropenem, imipenem, and the monobactam aztreonam. The antibiotic resistance (mexA, mexB, and oprM) and the biofilm formation (pslA and pslD) genes were detected in all strains. Differences were found between strains in accessory genome size. The strains had different sequence types, and seven strains had sequence types associated with global high risk epidemic PA clones. All strains were represented in two groups among PA global strains. In the 17 strains, horizontally acquired resistance genes to aminoglycosides and beta-lactams were found, mainly, and between 230 and 240 genes that encode virulence factors. The strains under study were variable in terms of their accessory genome, antibiotic resistance, and virulence genes. With these characteristics, we provide information about the genomic diversity of clinically relevant PA strains.


  • Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis

    by María José Martínez-Gallardo, Claudia Villicaña, Martha Yocupicio-Monroy, Sofía Lizeth Alcaraz-Estrada, Josefina León-Félix

    Pseudomonas aeruginosa (PA) is considered the first causal agent of morbidity and mortality in people with cystic fibrosis (CF) disease. Multi-resistant strains have emerged due to prolonged treatment with specific antibiotics, so new alternatives have been sought for their control. In this context, there is a renewed interest in therapies based on bacteriophages (phages) supported by several studies suggesting that therapy based on lytic phages and biofilm degraders may be promising for the treatment of lung infections in CF patients. However, there is little clinical data about phage studies in CF and the effectiveness and safety in patients with this disease has not been clear. Therefore, studies regarding on phage characterization, selection, and evaluation in vitro and in vivo models will provide reliable information for designing effective cocktails, either using mixed phages or in combination with antibiotics, making a great progress in clinical research. Hence, this review focuses on the most relevant and recent findings on the activity of lytic phages against PA strains isolated from CF patients and hospital environments, and discusses perspectives on the use of phage therapy on the treatment of PA in CF patients.


  • Open Access

    miR-927 has pro-viral effects during acute and persistent infection with dengue virus type 2 in C6/36 mosquito cells

    by Rodolfo Gamaliel Avila-Bonilla, Martha Yocupicio-Monroy, Laurence A. Marchat, David Guillermo Pérez-Ishiwara, Doris Atenea Cerecedo-Mercado, Rosa María del Ángel, Juan Santiago Salas-Benito

    Dengue virus (DENV) is an important flavivirus that is transmitted to humans byAedesmosquitoes, where it can establish a persistent infection underlying vertical and horizontal transmission. However, the exact mechanism of persistent DENV infection is not well understood. Recently miR-927 was found to be upregulated in C6/36-HT cells at 57 weeks of persistent infection (C6-L57), suggesting its participation during this type of infection. The aim of this study was to determine the role of miR-927 during infection with DENV type 2. The results indicate an overexpression of miR-927 in C6-L57 cells and acutely infected cells according to the time of infection and the m.o.i. used. The downregulation of miR-927 in C6-L57 cells results in a reduction of both viral titre and viral genome copy number. The overexpression of miR-927 in C6-L40 and C6/36 cells infected at an m.o.i. of 0.1 causes an increase in both viral titre and viral genome copy number, suggesting a pro-viral activity of miR-927.In silicoprediction analysis reveals target mRNAs for miR-927 are implicated in post-translational modifications (SUMO), translation factors (eIF-2B), the innate immune system (NKIRAS), exocytosis (EXOC-2), endocytosis (APM1) and the cytoskeleton (FLN). The expression levels of FLN were the most affected by both miR-927 overexpression and inhibition, and FLN was determined to be a direct target of miR-927 by a dual-luciferase gene reporter assay. FLN has been associated with the regulation of the Toll pathway and either overexpression or downregulation of miR-927 resulted in expression changes of antimicrobial peptides (Cecropins A and G, and Defensin D) involved in the Toll pathway response.


  • Open Access

    Natural Vertical Transmission of Zika Virus in Larval Aedes aegypti Populations, Morelos, Mexico

    by Mónica Izquierdo-Suzán, Selene Zárate, Jesús Torres-Flores, Fabián Correa-Morales, Cassandra González-Acosta, Edgar E. Sevilla-Reyes, Rosalia Lira, Sofía L. Alcaraz-Estrada, Martha Yocupicio-Monroy

    Vertical Transmission of Zika Virus in A. aegypti


  • Complete genome of DENV2 isolated from mosquitoes in Mexico

    by Selene Zárate, Fabiola Hernández-Perez, Blanca Taboada, Norma E. Martínez, Sofía L. Alcaráz-Estrada, Oscar del Moral, Martha Yocupicio-Monroy


  • Open Access

    Congenital Zika Syndrome and Extra-Central Nervous System Detection of Zika Virus in a Pre-term Newborn in Mexico

    by Maria Yolotzin Valdespino-Vázquez, Edgar E Sevilla-Reyes, Rosalia Lira, Martha Yocupicio-Monroy, Elvira Piten-Isidro, Celia Boukadida, Rogelio Hernández-Pando, Juan David Soriano-Jimenez, Alma Herrera-Salazar, Ricardo Figueroa-Damián, et al.

    During pregnancy, the Zika virus (ZIKV) replicates in the placenta and central nervous system (CNS) of infected fetuses; nevertheless, the ability of ZIKV to replicate in other fetal tissues has not been extensively characterized. We researched whether dissemination of congenitally-acquired ZIKV outside the CNS exists by searching for the accumulation of the viral envelope protein, ZIKV ribonucleic acid (RNA), and infectious viral particles in different organs of a deceased newborn with Congenital Zika Syndrome. A real-time qualitative polymerase chain reaction (qPCR) was used to detect ZIKV RNA in the brain, thymus, lungs, kidneys, adrenal glands, spleen, liver, and small intestine. The same tissues were analyzed by indirect immunofluorescence and immunoperoxidase assays using the monoclonal antibody 4G2 to detect ZIKV envelope antigens. Isolation of infectious ZIKV in a cell culture was carried out using brain and kidney samples. A postmortem, virological analysis of multiple organs, such as the kidneys (epithelial cells in the renal tubules), lungs (bronchial epithelia), thymus (epithelial cells inside the Hassall’s corpuscles), and brain (neurons, ependymal cells, and macrophages) revealed the presence of ZIKV RNA and envelope antigens. Other tissues of the deceased newborn tested positive by qPCR for Epstein-Barr virus and human herpesvirus 6, including the brain cortex (Epstein-Barr) and the thymus, kidneys, and adrenal glands (human herpesvirus 6). The kidneys were identified as a significant niche for viral replication, given that infectious particles were successfully isolated from renal tissues. Our findings demonstrate the ability of congenitally-acquired ZIKV to produce disseminated infections and the viral tropism towards epithelial cells.


  • Dengue virus induced changes in Ca 2+ homeostasis in human hepatic cells that favor the viral replicative cycle

    by Cinthia L. Dionicio, Franshelle Peña, Luis A. Constantino-Jonapa, Carlos Vazquez, Martha Yocupicio-Monroy, Romel Rosales, José Luis Zambrano, Marie Christine Ruiz, Rosa M. del Angel, Juan E. Ludert


  • Human Virome

    by Selene Zárate, Blanca Taboada, Martha Yocupicio-Monroy, Carlos F. Arias


  • Open Access

    Complete Genome Sequences, before and after Mammalian Cell Culture, of Zika Virus Isolated from the Serum of a Symptomatic Male Patient from Oaxaca, Mexico

    by Celia Boukadida, Jesús M. Torres-Flores, Martha Yocupicio-Monroy, Elvira Piten-Isidro, Amaranta Y. Rivero-Arrieta, Yara A. Luna-Villalobos, Liliane Martínez-Vargas, Sofía L. Alcaraz-Estrada, Klintsy J. Torres, Rosalia Lira, et al.

    Zika virus (ZIKV) is an emerging arthropod-borne flavivirus associated with severe congenital malformations and neurological complications. Although the ZIKV genome is well characterized, there is limited information regarding changes after cell isolation and culture adaptation. We isolated, and passaged in Vero cells, ZIKV from the serum of a symptomatic male patient and compared the viral genomes before and after culture. Single nucleotide polymorphisms were characteristic among serum-circulating genomes, while such diversity decreased after cell culture.


  • Analysis of the miRNA profile in C6/36 cells persistently infected with dengue virus type 2

    by Rodolfo Gamaliel Avila-Bonilla, Martha Yocupicio-Monroy, Laurence A. Marchat, Mónica A. De Nova-Ocampo, Rosa María del Ángel, Juan Santiago Salas-Benito